Article
Medical Laboratory Technology
Stephen Boone, W. Frank Peacock, Alan H. B. Wu, Allan Jaffe, Robert H. Christenson, Frederic M. Ettner, Shahriar Dadkhah
Summary: This study aimed to evaluate troponin testing in transgender patients. The results showed that in stable transgender patients without congestive heart failure or chronic kidney disease, no differences were observed in troponin concentrations between transgender women and transgender men. Meaningful conclusions are limited due to inadequate sample size and population differences. Further research on troponin concentrations in this underrepresented, vulnerable population is needed.
CLINICA CHIMICA ACTA
(2023)
Review
Cardiac & Cardiovascular Systems
Inbar Raber, Cian P. McCarthy, James L. Januzzi
Summary: High-sensitivity cardiac troponin assays can rapidly identify or exclude acute myocardial injury, providing faster evaluation for acute myocardial infarction, while also opening up possibilities for other cardiovascular risk assessments. The optimal hs-cTn threshold varies depending on the situation, and this review discusses how these assays can be interpreted for different applications.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Kirsty McDowell, Ross Campbell, Joanne Simpson, Jonathan W. Cunningham, Akshay S. Desai, Pardeep S. Jhund, Martin P. Lefkowitz, Jean L. Rouleau, Karl Swedberg, Michael R. Zile, Scott D. Solomon, Milton Packer, John J. V. McMurray
Summary: This study investigated the improvement in risk prediction of heart failure by adding candidate biomarkers to comprehensive models with routinely collected clinical and laboratory variables. Four biomarkers (hs-TnT, GDF-15, cystatin C, and TIMP-1) were independently associated with all outcomes. However, only hs-TnT remained an independent predictor of the three endpoints when all biomarkers were added simultaneously to the PREDICT-HF model. Individually or in combination, the other biomarkers did not significantly improve discrimination or reclassification of prediction.
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Article
Oncology
Chun-Chieh Huang, I-Chieh Chuang, Yu-Li Su, Hao-Lun Luo, Ya-Chun Chang, Jo-Ying Chen, Chang-Chun Hsiao, Eng-Yen Huang
Summary: This study investigated the role of tumor galectin-1 and galectin-3 in patients with lung adenocarcinoma after radiation therapy. The results showed that overexpression of tumor galectin-1 was associated with worse locoregional progression-free survival, while galectin-3 overexpression had no significant effect on survival outcomes.
FRONTIERS IN ONCOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Julia Karady, Thomas Mayrhofer, Maros Ferencik, John T. Nagurney, James E. Udelson, Andreas A. Kammerlander, Jerome L. Fleg, W. Frank Peacock, James L. Januzzi, Wolfgang Koenig, Udo Hoffmann
Summary: The study aimed to quantify differences between high-sensitivity cardiac troponin (hs-cTn) assays and determine whether these differences may result in different management recommendations for patients with suspected acute coronary syndrome (ACS).
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Jacopo Sabbatinelli, Angelica Giuliani, Anna Rita Bonfigli, Deborah Ramini, Giulia Matacchione, Carla Campolucci, Artan Ceka, Elena Tortato, Maria Rita Rippo, Antonio Domenico Procopio, Marco Moretti, Fabiola Olivieri
Summary: sST2, hs-cTnI, and NT-proBNP are associated with 15-year mortality and onset of CV events in T2DM.
CARDIOVASCULAR DIABETOLOGY
(2022)
Article
Geriatrics & Gerontology
Alessio Menditto, Olga Protic, Mirko Di Rosa, Anna Rita Bonfigli, Fabrizia Lattanzio, Roberto Antonicelli
Summary: This study validates the prognostic role of cardiac troponin in elderly and very elderly COVID-19 patients, providing important clinical information for risk stratification.
ARCHIVES OF GERONTOLOGY AND GERIATRICS
(2023)
Article
Medical Laboratory Technology
Kwaku Tawiah, Laurel Jackson, Catherine Omosule, Claire Ballman, Bobby Shahideh, Mitchell G. Scott, Gillian Murtagh, Christopher W. Farnsworth
Summary: This study aimed to assess the prognostic and predictive capability of multiple biomarkers in COVID-19 patients. The results showed that baseline hsTnI was the most accurate biomarker for predicting 30-day mortality and the need for intubation. Increasing hsTnI concentrations were associated with poorer survival and higher 30-day mortality risk.
CLINICAL BIOCHEMISTRY
(2022)
Review
Cardiac & Cardiovascular Systems
Luis Leite, Pedro Matos, Antonio Leon-Justel, Claudio Espirito-Santo, Luis Rodriguez-Padial, Fernando Rodrigues, Domingo Orozco, Josep Redon
Summary: There are several approaches to building charts for cardiovascular (CV) risk, all of which have strengths and limitations. Early organ damage identification provides relevant information but its direct relationship with risk is imprecise, and its use is limited by operator variability and low availability in some healthcare systems. Biomarkers such as troponin (cTns) isoforms cTnI and cTnT have the advantage of being relatively reproducible, more accessible, and applicable to different populations. New and improved troponin assays perform well, can measure very low levels of circulating troponin with low intra-individual variation below 10%. Studies have shown that high sensitivity hs-cTnI has a place as an additional clinical marker in current CV risk charts, reflecting sex- and age-dependent differences. Although there are still some questions to be answered before recommending cTnI for assessing CV risk in primary prevention, it seems to be a potential strong marker to complement CV risk charts.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Wei Sun, Yanting Zhang, Chun Wu, Yuji Xie, Li Peng, Xiu Nie, Cheng Yu, Yi Zheng, Yuman Li, Jing Wang, Yali Yang, Qing Lv, Li Zhang, Cynthia C. Taub, Mingxing Xie
Summary: The study found that the combination of ventricular longitudinal strain with high-sensitivity troponin I (hs-TNI) can provide higher accuracy for predicting mortality in COVID-19 patients, which may enhance risk stratification in COVID-19 patients.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
(2021)
Article
Medicine, General & Internal
Yingchao Zhu, Yaodan Bi, Qian Yu, Bin Liu
Summary: This study explored the association between high-sensitive cardiac troponin T (hs-cTnT) and long-term mortality after noncardiac surgery. It found a significant association between elevated preoperative hs-cTnT concentrations and long-term mortality, one-third of which can be accounted for by myocardial injury.
FRONTIERS IN MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
Bjorn Wagner, Norbert Weidner, Andreas Hug
Summary: This study found that SCI patients frequently have elevated concentrations of high-sensitivity cardiac troponin T (hs-cTnT) without clinical evidence of myocardial injury. Clinicians must be aware of false-positive results of cTnT in skeletal muscle in SCI, including elevated baseline concentrations and troponin dynamics in serial measurements. Simultaneous analysis of cTnI may be helpful in cases of diagnostic uncertainty.
INTERNATIONAL JOURNAL OF CARDIOLOGY
(2023)
Article
Cardiac & Cardiovascular Systems
Pengchao Tian, Xuemei Zhao, Liyan Huang, Jiayu Feng, Lang Zhao, Lin Liang, Boping Huang, Yuhui Zhang, Jian Zhang
Summary: High-sensitivity cardiac troponin I provides significant prognostic value in non-ischaemic heart failure patients, with high levels associated with a higher risk of all-cause mortality. Its inclusion in risk prediction models improves risk stratification and prediction capabilities.
Article
Physiology
Alba Maestro-Benedicto, Mercedes Rivas-Lasarte, Juan Fernandez-Martinez, Laura Lopez-Lopez, Eduard Sole-Gonzalez, Vicens Brossa, Sonia Mirabet, Eulalia Roig, Juan Cinca, Jesus Alvarez-Garcia, Alessandro Sionis
Summary: Adding lung ultrasound (LUS) evaluation at discharge can improve the predictive value of most contemporary heart failure (HF) risk scores.
FRONTIERS IN PHYSIOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Daan Ceelen, Adriaan A. Voors, Jasper Tromp, Dirk J. van Veldhuisen, Kenneth Dickstein, Rudolf A. de Boer, Chim C. Lang, Stefan D. Anker, Leong L. Ng, Marco Metra, Piotr Ponikowski, Sylwia M. Figarska
Summary: Using pathway over-representation analysis of 363 circulating biomarkers, we identified activated pathophysiological pathways related to elevated plasma growth differentiation factor 15 (GDF-15) levels in patients with heart failure (HF). Patients with HF with high plasma concentrations of GDF-15 were characterized by increased activation of inflammatory pathways and pathways related to insulin-like growth factor (IGF)-1 regulation and bone/tissue remodelling.
EUROPEAN JOURNAL OF HEART FAILURE
(2022)
Article
Cardiac & Cardiovascular Systems
Ankeet S. Bhatt, Mikhail N. Kosiborod, Muthiah Vaduganathan, Brian L. Claggett, Z. Michael Miao, Ian J. Kulac, Carolyn S. P. Lam, Adrian F. Hernandez, Felipe Martinez, Silvio E. Inzucchi, Sanjiv J. J. Shah, Rudolf A. de Boer, Pardeep S. Jhund, Akshay S. Desai, Magnus Petersson, Anna Maria Langkilde, John J. V. McMurray, Scott D. Solomon
Summary: In this study, the effects of dapagliflozin on health status in heart failure patients were examined. The results showed that dapagliflozin improved health status in patients across the full range of left ventricular ejection fraction (LVEF).
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Article
Cardiac & Cardiovascular Systems
Safia Chatur, Jonathan W. Cunningham, Muthiah Vaduganathan, Finnian R. Mc Causland, Brian L. Claggett, Akshay S. Desai, Zi Michael Miao, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail N. Kosiborod, Carolyn S. P. Lam, Felipe A. Martinez, Sanjiv J. Shah, Magnus Petersson, Anna Maria Langkilde, John J. V. McMurray, Scott D. Solomon
Summary: In patients recently hospitalized for heart failure, dapagliflozin can reduce the risk of hospitalization and has minimal effects on blood pressure and renal function. It is a safe and effective treatment option for stabilized patients with heart failure.
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Article
Cardiac & Cardiovascular Systems
Safia Chatur, Toru Kondo, Brian L. Claggett, Kieran Docherty, Zi Michael Miao, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail N. Kosiborod, Carolyn S. P. Lam, Felipe A. Martinez, Sanjiv J. J. Shah, Magnus Petersson, Anna Maria Langkilde, John J. V. McMurray, Scott D. Solomon, Muthiah Vaduganathan
Summary: Dapagliflozin significantly reduces both first and recurrent HF hospitalizations in patients with HF, regardless of ejection fraction. However, the impact of dapagliflozin on different types of HF hospitalizations has not been well studied.
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Article
Cardiac & Cardiovascular Systems
Mark Jansen, A. F. Schmidt, J. J. M. Jans, I. Christiaans, S. N. van der Crabben, Y. M. Hoedemaekers, D. Dooijes, J. D. H. Jongbloed, L. G. Boven, R. H. Lekanne Deprez, A. A. M. Wilde, J. van der Velden, R. A. de Boer, J. P. van Tintelen, F. W. Asselbergs, A. F. Baas
Summary: In this study, acylcarnitines were evaluated as potential biomarkers for hypertrophic cardiomyopathy (HCM). The study found that several acylcarnitines were significantly increased in patients with severe HCM, and some were also increased in patients with mild HCM. Additionally, certain acylcarnitines were associated with measures of HCM severity. Prospective studies are needed to further investigate the prognostic value of these biomarkers.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
(2023)
Review
Oncology
Laura I. Yousif, Elles M. Screever, Danielle Versluis, Joseph Pierre Aboumsallem, Stefan Nierkens, Olivier C. Manintveld, Rudolf A. de Boer, Wouter C. Meijers
Summary: This review discusses the four main risk factors for immune checkpoint inhibitor-related cardiovascular adverse events (irAEs), including ICI combination therapy, combination with other anti-cancer treatments, female sex, pre-existing cardiovascular disease, and specific tumors. An a priori risk strategy is needed to determine who is at risk for developing these cardiovascular irAEs, and a better understanding of the impact of risk factors is crucial for improving care and disease management in these patients.
CURRENT ONCOLOGY REPORTS
(2023)
Article
Cardiac & Cardiovascular Systems
Ali A. A. Al-Mubarak, Niels Grote Beverborg, Victor Zwartkruis, Colinda van Deutekom, Martin H. H. de Borst, Ron T. T. Gansevoort, Stephan J. L. Bakker, Daan J. J. Touw, Rudolf A. A. de Boer, Peter van der Meer, Michiel Rienstra, Nils Bomer
Summary: This study aimed to investigate the association between micronutrient deficiencies and the development of atrial fibrillation (AFib). Selenium deficiency was found to be associated with new-onset AFib in non-smoking participants.
CLINICAL RESEARCH IN CARDIOLOGY
(2023)
Article
Cardiac & Cardiovascular Systems
Elena Arbelo, Alexandros Protonotarios, Juan R. Gimeno, Eloisa Arbustini, Roberto Barriales-Villa, Cristina Basso, Connie R. Bezzina, Elena Biagini, Nico A. Blom, Rudolf A. de Boer, Tim De Winter, Perry M. Elliott, Marcus Flather, Pablo Garcia-Pavia, Kristina H. Haugaa, Jodie Ingles, Ruxandra Oana Jurcut, Sabine Klaassen, Giuseppe Limongelli, Bart Loeys, Jens Mogensen, Iacopo Olivotto, Antonis Pantazis, Sanjay Sharma, J. Peter Van Tintelen, James S. Ware, Juan Pablo Kaski
EUROPEAN HEART JOURNAL
(2023)
Article
Cardiac & Cardiovascular Systems
Jawad H. Butt, Henri Lu, Toru Kondo, Erasmus Bachus, Rudolf A. de Boer, Silvio E. Inzucchi, Pardeep S. Jhund, Mikhail N. Kosiborod, Carolyn S. P. Lam, Felipe A. Martinez, Muthiah Vaduganathan, Scott D. Solomon, John J. V. Mcmurray
Summary: Chronic obstructive pulmonary disease (COPD) is common in heart failure patients with mildly reduced ejection fraction or preserved ejection fraction (HFmrEF/HFpEF) and is associated with worse outcomes. The study found that dapagliflozin has consistent benefits on clinical events and symptoms regardless of COPD status.
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Review
Cardiac & Cardiovascular Systems
Abdul Shakoor, Sabrina Abou Kamar, Jishnu Malgie, Isabella Kardys, Jeroen Schaap, Rudolf A. de Boer, Nicolas M. van Mieghem, Robert M. A. van der Boon, Jasper J. Brugts
Summary: This meta-analysis study confirms the difference in adverse outcome risks among different stages of heart failure (HF) and highlights the negative prognostic value of worsening HF (WHF) as the initial progressive stage from chronic HF (CHF) to advanced HF.
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Article
Endocrinology & Metabolism
Victor W. Zwartkruis, Navin Suthahar, Demy L. Idema, Belend Mahmoud, Colinda van Deutekom, Frans H. Rutten, Yvonne T. van der Schouw, Michiel Rienstra, Rudolf A. de Boer
Summary: The study found that relative fat mass (RFM) is an emerging marker of obesity that estimates body fat percentage. RFM was significantly associated with incident atrial fibrillation (AF), heart failure (HF), and coronary artery disease (CAD), and potential RFM cutoffs for cardiovascular disease (CVD) prediction were determined. This study provides useful information for future preventive strategies targeting obesity and cardiovascular risk.
INTERNATIONAL JOURNAL OF OBESITY
(2023)
Editorial Material
Cardiac & Cardiovascular Systems
Rudolf A. de Boer
NETHERLANDS HEART JOURNAL
(2023)
Meeting Abstract
Cardiac & Cardiovascular Systems
Peikert, P. Goyal, M. Vaduganathan, B. L. Claggett, A. S. Desai, P. S. Jhund, M. N. Kosiborod, C. S. P. Lam, S. E. Inzucchi, F. A Martinez, R. A. De Boer, A. F. Hernandez, S. J. Shah, J. J. V. Mcmurray, S. D. Solomon
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Meeting Abstract
Cardiac & Cardiovascular Systems
T. B. Petersen, N. Suthahar, F. W. Asselbergs, M. De Bakker, K. M. Akkerhuis, A. A. Constantinescu, J. Van Ramshorst, P. D. Katsikis, P. J. Van Der Spek, V. A. Umans, R. A. De Boer, E. Boersma, D. Rizopoulos, I. Kardys
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Meeting Abstract
Cardiac & Cardiovascular Systems
N. T. B. Niels Tjeerd Benjamin Scholte, M. T. Gurgoze, D. Aydin, D. A. M. J. Theuns, O. C. Manintveld, E. Ronner, E. Boersma, R. A. De Boer, R. M. A. Van der Boon, J. J. Brugts
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Meeting Abstract
Cardiac & Cardiovascular Systems
N. Suthahar, V. Z. Zwartkruis, S. J. L. Bakker, R. T. Gansevoort, I. Kardys, E. Boersma, R. A. De Boer
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Editorial Material
Cardiac & Cardiovascular Systems
Jose E. Exaire, Timothy A. Mixon
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Giuseppe Di Gioia, Federica Coletti, Lorenzo Buzzelli, Viviana Maestrini, Sara Monosilio, Andrea Segreti, Maria Rosaria Squeo, Erika Lemme, Antonio Nenna, Antonio Pelliccia
Summary: Dyslipidemia is common in Paralympic athletes, with lipid levels influenced by the type of disability and sporting discipline.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Esra Donmez, Sevgi Ozcan, Irfan Sahin, Murat Ziyrek, Ertugrul Okuyan
Summary: This study aimed to evaluate the predictive value of the GRACE risk score in acute pulmonary embolism (PE) patients for 30-day mortality and the need for thrombolytic treatment. The study found that the GRACE risk score, along with the PESI score, were independent risk factors associated with 30-day mortality and the need for thrombolytic treatment. The GRACE risk score showed high sensitivity and specificity in predicting mortality, and its combination with the PESI score helped define high-risk PE patients and predict poor prognosis.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Tom Kai Ming Wang, Reza Reyaldeen, Kevser Akyuz, Zoran B. Popovic, A. Marc Gillinov, Bo Xu, Brian P. Griffin, Milind Y. Desai
Summary: Transthoracic echocardiography (TTE) is commonly used to evaluate isolated tricuspid regurgitation (TR), but there is limited research comparing its quantification with magnetic resonance imaging (MRI). In this study, a novel TTE algorithm was developed to identify severe TR based on TTE parameters. The algorithm had a higher accuracy than the current guidelines' criteria in detecting severe TR by MRI.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Editorial Material
Cardiac & Cardiovascular Systems
Enkhtsogt Sainbayar, Ramzi Ibrahim, Hoang Nhat Pham, Wisam Beauti, Mahek Shahid, Natalie Hickerson, Mohammed Salih, Joao Paulo Ferreira, Mamas A. Mamas
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Richard E. Casazza, Hymie Chera, Carlos Adolfo Rodriguez, Sergey Ayzenberg
Summary: This article presents a case of a patient with known situs inversus who underwent cardiac catheterization and was found to have chronic total occlusion in the right coronary artery. Situs inversus is a rare congenital abnormality characterized by the inverted position of chest and abdominal organs. Cardiac catheterization is uncommon in patients with this particular abnormality, highlighting the importance of customizing techniques to engage coronary arteries and optimize guide support for percutaneous coronary intervention if needed.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Editorial Material
Cardiac & Cardiovascular Systems
Georgiana Pintea Bentea, Brahim Berdaoui, Sophie Samyn, Marielle Morissens, Philippe van de Borne, Jose Castro Rodriguez
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Bulbul Ahmed, Melissa G. Farb, Shakun Karki, Sophia D'Alessandro, Niloo M. Edwards, Noyan Gokce
Summary: This study evaluated the angiogenic capacity of adipose tissue in patients undergoing cardiac surgeries and found that patients with coronary artery disease (CAD) had reduced angiogenic capacity in their pericardial adipose tissue. Gene expression analysis revealed upregulated expression of the anti-angiogenic gene TSP-1 in CAD patients, with no significant differences in other angiogenic factors. Additionally, inhibiting TSP-1 expression significantly improved angiogenic deficiency in CAD patients.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Moshe Rav-Acha, Orli Wube, Oholi Tovia Brodie, Yoav Michowitz, Michael Ilan, Tal Ovdat, Robert Klempfner, Mahmud Suleiman, Ilan Goldenberg, Michael Glikson
Summary: The current guidelines recommend prophylactic implantable cardioverter-defibrillator (ICD) for patients with symptomatic heart failure (HF) and low left ventricular ejection fraction. However, not all patients will benefit from ICD treatment. This study evaluated the feasibility of using the MADIT-II-based Risk Stratification Score (MRSS) to predict the survival benefit of prophylactic ICDs in patients with HF. The results showed that different risk subgroups had varying levels of ICD survival benefit.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Ariel Banai, Rachel Retsky, Lior Lupu, Erez Levi, David Zahler, Omri Feder, Roei Merin, Yan Topilsky, Raphael Rosso, Shmuel Banai, Sami Viskin, Ehud Chorin
Summary: This study aims to evaluate the association between electromechanical window (EMW) and ventricular tachyarrhythmias in patients with Takotsubo syndrome (TTS). The study found that TTS patients had a lower EMW value, which was associated with an increased risk of ventricular tachyarrhythmias.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Harun Kundi, Kobina Hagan, Tamer Yahya, Garima Sharma, Sadeer Al-Kindi, Zulqarnain Javed, Khurram Nasir
Summary: Using latent class analysis (LCA), the study identified clinical, demographic, and social subphenotypes in ASCVD population and assessed the risk of all-cause and cardiovascular mortality across different socioclinical classes. The results showed that the younger, female, non-Hispanic Black or Hispanic individuals with a high burden of co-morbidities and unfavorable social determinants of health had the highest risk of mortality in the identified latent classes.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Moises A. Vasquez, Mina Iskander, Mohammed Mustafa, Juan A. Quintero-Martinez, Antonio Luna, Joel Mintz, Jose Noy, Juan Uribe, Ivan Mijares, Eduardo de Marchena, Yiannis S. Chatzizisis
Summary: The benefits of pericardiocentesis (PC) in patients with pulmonary hypertension (PH) and pericardial effusions are unclear. The study found that PC in PH patients is associated with higher in-hospital mortality and rates of cardiovascular complications.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Ken Kuwajima, Mana Ogawa, Irving Ruiz, Hiroko Hasegawa, Nobuichiro Yagi, Florian Rader, Robert J. Siegel, Takahiro Shiota
Summary: After cardiac surgery, the longitudinal function of the right ventricle and left ventricle is reduced, despite preserved global functions. In particular, tricuspid annular plane systolic excursion (TAPSE) remains decreased after surgery.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Min -Jung Kim, Robert H. Aseltine Jr, Sara R. Tabtabai
Summary: This study evaluated the rates and causes of 30-day readmissions after discharge for heart failure (HF) as a primary and secondary diagnosis. The findings indicate that efforts to reduce readmission rates should include patients with secondary HF diagnosis, and surveillance should extend to 2 weeks postdischarge to identify at-risk patients.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
Article
Cardiac & Cardiovascular Systems
Ya He, Jianzhong Zhou
Summary: This study aimed to examine the relation between reverse septal curvature (RSC) and nonsustained ventricular tachycardia (NSVT) in patients with hypertrophic cardiomyopathy (HCM). The study found that patients with RSC were younger and had a higher incidence of NSVT, and RSC was identified as a strong independent risk factor for NSVT.
AMERICAN JOURNAL OF CARDIOLOGY
(2024)
